New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
04:55 EDTCYH, CYH, BAX, BAX, CAH, CAH, KND, KND, CRY, CRY, MDCO, MDCO, SRDX, SRDX, XOMA, XOMA, PRGO, PRGO, IDRA, IDRA, EBS, EBS, CVS, CVSRBC Capital to hold a conference
Healthcare Conference is being held in New York on February 25-26.
News For CYH;EBS;IDRA;PRGO;XOMA;SRDX;MDCO;CRY;KND;CAH;BAX;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 30, 2015
10:57 EDTPRGOPerrigo completes acquisition of Omega Pharma for EUR3.8B
Subscribe for More Information
07:05 EDTMDCOThe Medicines Co. receives EC approval for three hospital acute care products
Subscribe for More Information
March 27, 2015
11:33 EDTPRGOPerrigo management to meet with Jefferies
Subscribe for More Information
08:44 EDTMDCOThe Medicines Co. has a conference call hosted by JPMorgan
Subscribe for More Information
07:45 EDTPRGOFDA to hold a public meeting
Subscribe for More Information
06:08 EDTMDCOThe Medicines Co. assumed with a Neutral at Citigroup
Target $30.
March 26, 2015
07:30 EDTPRGODeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 25, 2015
16:37 EDTCVSSpecialists On Call names Hammad Shah as CEO
Subscribe for More Information
11:45 EDTCVS, CAHLeerink healthcare tech/pharma analysts hold analyst/industry conference call
Subscribe for More Information
07:12 EDTMDCO, BAXAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
07:08 EDTEBSEmergent BioSolutions receives FDA approval of Anthrasil
Emergent BioSolutions announced that the FDA has approved Anthrasil, Anthrax Immune Globulin Intravenous, also known as AIGIV, for treatment of inhalational anthrax in combination with appropriate antibacterial drugs. Achievement of this milestone triggers a $7M payment to the company under a development contract with the Biomedical Advanced Research and Development Authority. Anthrasil has received Orphan Drug designation and as a result of this approval, the product qualifies for seven years of market exclusivity.
March 24, 2015
07:13 EDTEBSEmergent BioSolutions awarded $31M contract for advanced development of NuThrax
Subscribe for More Information
March 23, 2015
10:00 EDTPRGOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTIDRAIdera Pharmaceuticals Chief Medical Officer resigns
Idera Pharmaceuticals disclosed in a regulatory filing that Louis Brenner, M.D. resigned his positions as senior VP and Chief Medical Officer of Idera to accept a new role as the Chief Operating Officer of a privately-held biotechnology company. This change will become effective April 3.
08:07 EDTCYH, KNDBofA/Merrill healthcare high yield analyst has analyst/industry conference call
Healthcare High Yield Analyst Bland provides an update on the current state of the bond markets and the ability of healthcare providers to utilize debt financing on an Analyst/Industry conference call to be held on March 24 at 10 am.
06:25 EDTPRGOPerrigo downgraded to Sector Perform from Outperform at RBC Capital
March 20, 2015
10:00 EDTMDCOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:18 EDTCYHLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses Sustainable Growth Rate (SGR) and the proposed pay-fors and implications For Healthcare Services on an Analyst/Industry conference call to be held on March 20 at 11 am.
March 19, 2015
16:06 EDTMDCOThe Medicines Co. initiated with a Neutral at Mizuho
Subscribe for More Information
March 18, 2015
08:11 EDTSRDXSurModics contributed in vitro diagnostic component to smartphone HIV device
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use